Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models

Current Gene Therapy

Volumn 8, Issue 1, 2008, Pages 49-53

  Morel, Gustavo R ^a   Reggiani, Paula C ^a   Console, Gloria M ^a   Rimoldi, Omar J ^a   Vesenbeckh, Silvan M ^b   Garcia Bravo, Margarita M ^a   Rodriguez, Silvia S ^a   Brown, Oscar A ^a   Goya, Rodolfo G ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antiinflammatory therapy; Lipids; Nude reproductive derangements; Synthetic gene; Thymulin; Thymus pituitary axis

Indexed keywords

ADENOVIRUS VECTOR; THYMULIN; THYMUS HORMONE;

ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; DNA SEQUENCE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SYNTHESIS; DRUG TRANSPORT; ENCEPHALITIS; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HYPERGLYCEMIA; HYPOPHYSIS DISEASE; IMMUNOMODULATION; IMMUNOPATHOLOGY; LIPID METABOLISM; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; NONHUMAN; NONVIRAL GENE THERAPY; NUDE MOUSE; OVARY DISEASE; PUBERTY; REPORTER GENE; REVIEW; SINGLE DRUG DOSE; THYMUS DISEASE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS STRAIN;

AGING; ANIMALS; BASE SEQUENCE; GENE THERAPY; IMMUNITY, NATURAL; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEQUENCE HOMOLOGY, NUCLEIC ACID; THYMIC FACTOR, CIRCULATING; THYMUS GLAND;

ANIMALIA; MUS; MUS MUSCULUS; RATTUS;

EID: 41749104640     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652308783688518     Document Type: Review

References (41)

1. Bach JF, Bach AM, Dardenne M, Pléau J-M. The target cell of thymic hormones. In: Ed Le Douarin N, Cell Lineage, Stem Cells and Cell Determination. Amsterdam, Elsevier/North-Holland Biomedical Press; pp. 261-268 (1979).
2. Hall NR, McGillis JP, Spangelo BL, Goldstein AL. Evidence that thymosin and other biological response modifiers can function as neuroactive immunotransmitters. J Immunol 135: 806s-811s (1985).
3. Savino W, Dardenne M. Neuroendocrine control of thymus physiology. Endocrine Rev 21: 412-443 (2000).
4. Goya RG, Brown OA, Pléau J-M, Dardenne M. Thymulin and the neuroendocrine system. Peptides 25: 139-142 (2004).
5. Comsa J. Thymus substitution and HTH, the homeostatic thymus hormone. In: Ed. Luckey TD, Thymic Hormones, Baltimore, University Park Press, pp. 39-58 (1973).
6. Deschaux P, Dodin A, Laval F, Fontanges R. Role of two thymic extracts in the protective mechanisms against an experimental infection (in French). C R Acad Sc Paris 281 (Serie D): 1443-1445 (1975).
7. Goya RG, Cónsole GM, Hereñú CB, Brown OA, Rimoldi OJ. Thymus and aging: Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models. Gerontology 48: 325-328 (2002).
8. Calenda A, Cordonnier A, Lederer F, Le DKII, Pléau J-M. Production of biologically active thymulin in Escherichia coli through expression of a chemically synthesized gene. Biotechnol Lett 10: 155-160 (1988).
9. Gastinel LN, Dardenne M, Pléau J-M, Bach JF. Studies on the zinc-binding site to the serum thymic factor. Biochim Biophys Acta 797: 147-155 (1984).
10. Dardenne M, Pléau J-M, Nabarra B, et al. Contribution of zinc and other metals to the biological activity of serum thymic factor (FTS). Proc Natl Acad Sci USA 79: 5370-5373 (1982).
11. Reggiani PC, Hereñu CB, Rimoldi OJ, et al. Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. Gene Ther 13: 1214-1221 (2006).
12. Hereñú CB, Cristina C, Rimoldi OJ, et al. Restorative effect of Insulin-like Growth Factor-I gene therapy in the hypothalamus of senile rats with dopaminergic dysfunction Gene Ther 14: 237-245 (2007).
13. Choi-Lundberg DL, Lin Q, Chang YN, et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275: 838-841 (1997).
14. Morel GR, Brown OA, Reggiani PC, et al. Peripheral and mesencephalic transfer of a synthetic gene for the thymic peptide thymulin. Brain Res Bull 69: 647-651 (2006).
15. Safieh-Garabedian B, Dardenne M, Pleau J-M, Saade NE. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Br J Pharmacol 136: 947-955 (2002).
16. Safieh-Garabedian B, Ochoa-Chaar CI, Poole S, et al. Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection. Neuroscience 121: 865-873 (2003).
17. Lowenstein PR, Mandel RJ, Xiong WD, Kroeger K, Castro MG. Immune Responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. Curr Gene Ther 7: 347-360 (2007).
18. Stone D, Xiong W, Williams JC, David A, Lowenstein PR, Castro MG. Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral induced brain inflammation, but delays immune system-mediated elimination of transgene expression. Mol Ther 8: 400-411 (2003).
19. Besedovsky HO, Sorkin E. Thymus involvement in female sexual maturation. Nature 249: 356-358 (1974).
20. Rebar RW, Morandini IC, Erickson GF, Petze JE. The hormonal basis of reproductive defects in athymic mice. Endocrinology 108: 120-126 (1981).
21. Lintern-Moore S, Pantelouris EM. Ovarian development in athymic nude mice. I. The size and composition of the follicle population. Mech Age Devel 4: 385-390 (1975).
22. Michael SD, Taguchi O, Nishizuka Y. Effects of neonatal thymectomy on ovarian development and plasma LH, FSH, GH and PRL in the mouse. Biol Reprod 22: 343-350 (1980).
23. Nishizuka Y, Sakakura T. Ovarian dysgenesis induced by neonatal thymectomy in the mouse. Endocrinology, 89: 889-893 (1971).
24. Camihort G, Luna G, Vesenbeckh S, et al. Morphometric assessment of the impact of serum thymulin immunoneutralization on pituitary cell populations in peripubertal mice. Cells Tiss Organs 184: 23-30 (2006).
25. Zaidi SAA, Kendall MD, Gillham B, Jones MT. The release of LH from pituitaries perifused with thymic extracts. Thymus 12: 253-264 (1988).
26. Brown OA, Sosa YE, Dardenne M, Pléau J-M, Goya RG. Studies on the gonadotropin-releasing activity of thymulin: changes with age. J Gerontol A Biol Sci Med Sci 55: B170-B176 (2000).
27. Goya RG, Reggiani PC, Vesenbeckh SM, et al. Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice. Am J Physiol Endocrinol Metab 293: E182-E187 (2007).
28. Goya RG, Console GM, Sosa YE, Gomez Durmn CLA, Dardenne M. Altered functional responses with preserved morphology of gonadotrophic cells in congenitally athymic mice. Brain Behav Immun 15: 85-92 (2001).
29. Zeidler A, Tosco C, Kumar D, Slavin B, Parker J. Spontaneous hyperglycemia and impaired glucose tolerance in athymic nude BALB/c mice. Diabetes 31: 821-825 (1982).
30. Zeidler A, Kumar D, Johnson C, Parker J. Development of a diabetes-like syndrome in an athymic nude Balb/c mouse colony. Exp Cell Biol 52: 145-149 (1984).
31. Zeidler A, Shargill N S, Chan TM. Peripheral in sulin insensitivity in the hyperglycemic athymic nude mouse: similarity to noninsulin-dependent diabetes mellitus. Proc Sue Exp Biol Med 196: 457-460 (1991).
32. Zeidler A, Arbuckle S, Mahan E, et al. Assessment of pancreatic islet- cell population in the hyperglycemic athymic nude mouse: immunohistochemical, ultrastructural, and hormonal studies. Pancreas 4: 153-160 (1989).
33. Velkov Z, Zafirova M, Kemileva Z, Tarkolev N, Bojilova M. Time course changes in blood glucose and insulin levels of thymectomized rats. Acta Physiol Pharmacol Bulg 16: 64-67 (1990).
34. Mondola P, Coscia Porrazzi L, Falconi C. Cholesterol and triglycerides of a liver after administration of a chromatographic fraction of thymus: variations in tissue and blood. Horm Metab Res 11: 503-505 (1979).
35. Mondola P, Santillo M, Tedesco I, Santangelo F, Belfiore A, Bifulco M. Thymus fraction (FIII) effect on cholesterol metabolism: modulation of the low density lipoprotein receptor pathway. Int J Biochem 21: 627-630 (1989).
36. Mondola P, Santillo M, Santangelo F, Belfiore A, Gambardella P, Bifuco M. Effects of a new calf thymus protein on 3-hydroxy-3-methyl-glutarylCoA reductase activity in rat (rattus bubalus) hepatocyte cells (BRL-3A). Comp Biochem Physiol 103B (2): 431-434 (1992).
37. García-Bravo MM, Polo MP, Reggiani PC, Rimoldi OJ, Dardenne M, Goya RG. Partial prevention of hepatic lipid alterations in nude mice by neonatal thymmlin gene therapy. Lipids 41: 753-757 (2006).
38. Bach JF, Dardenne M, Goldstein AL. Clinical Aspects of thymulin (FTS). In: Ed Goldstein AL, Thymic Hormones and Lymphokines. Basic Chemistry and Clinical Applications. New York, Plenum Press, pp. 593-600 (1984).
39. Sztein MB, Goldstein AL. Thymic hormones -a clinical update. Springer Sem Immunopathol 9: 1-18 (1986).
40. McGeer PL, McGeer EG. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10 (Suppl. 1): S3-S7 (2004).
41. Safieh-Garabedian B, Kendall MD, Khamashta MA, Hughes GRV. Thymulin and its role in immunomodulation. J Autoimmune 5: 547-555 (1992).